InvestorsHub Logo
Followers 87
Posts 6669
Boards Moderated 1
Alias Born 09/18/2009

Re: Preciouslife1 post# 42020

Thursday, 03/07/2024 11:06:39 AM

Thursday, March 07, 2024 11:06:39 AM

Post# of 42837
Interesting niche. But I don't see anything about production turnaround, and it appears that their CAR-T is designed to enhance mitigation of CCR-9. I think Gracell's 24 hour turnaround for CAR-T is a much better, even revolutionary, alternative, which I hope that lenz is a part of making that happen.

I see that they also provide CRISPR services. I think that lenz was developed with that gene-editing technology. But even so, I'm not comfortable with it, generally. And I see that GenScript also provides mRNA solutions, and I am becoming increasingly wary of that.

Lots and lots of potential with those technologies, but way too much opportunity for abuse of those capabilities.

https://www.genscript.com/?src=google&utm_source=google&utm_medium=cpc&utm_campaign=GenScript-ECPC_NA&jiraid=12194&gad_source=1&gclid=EAIaIQobChMIzsnPnL_ihAMVGy7UAR2UUQsxEAAYASAAEgJy3vD_BwE